The tumor-specific de2-7 epidermal growth factor receptor (EGFR) promotes cells survival and heterodimerizes with the wild-type EGFR

Oncogene
Rodney B LuworTerrance G Johns

Abstract

Mutations of the epidermal growth factor receptor (EGFR) gene are found at a relatively high frequency in glioma, with the most common being the de2-7 EGFR (or EGFRvIII). This mutation arises from an in-frame deletion of exons 2-7, which removes 267 amino acids from the extracellular domain of the receptor. Despite being unable to bind ligand, the de2-7 EGFR is constitutively active and imparts a significant in vivo growth advantage to glioma cells. In order to examine the signalling pathways activated by the de2-7 EGFR and its biological effects in an in vitro system, the de2-7 EGFR gene was transfected into the murine IL-3-dependent pro-B-cell line BaF/3. Expression of the de2-7 EGFR enhanced the survival of BaF/3 cells in the absence of IL-3 by reducing apoptosis in a phosphatidylinositol 3-kinase (PI3-K)-dependent manner. Interestingly, while de2-7 EGFR also enhanced proliferation of BaF/3 cells in low levels of IL-3, this effect was independent of PI3-K. Survival and proliferation were further enhanced when BaF/3 cells were cotransfected with the de2-7 and wt EGFR. This was due to heterodimerization between the de2-7 and wt EGFR leading to trans-phosphorylation of the wt EGFR. This observation is directly relevant to gliom...Continue Reading

References

Jan 1, 1991·Methods in Enzymology·A LevitzkiC Gilon
Jan 1, 1991·The Biochemical Journal·P M SextonD M Findlay
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·N SugawaV P Collins
Jan 1, 1982·Journal of Cellular Biochemistry·M D WaterfieldB Ozanne
Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·R NishikawaH J Huang
Apr 30, 1998·Current Opinion in Cell Biology·J Downward
Jun 13, 1998·Journal of the National Cancer Institute·J Rubin GrandisD J Tweardy
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·J H WrightE G Krebs
Dec 2, 1999·Genes & Development·S R DattaM E Greenberg
Jan 19, 2000·British Journal of Cancer·E O Olapade-OlaopaF K Habib
May 9, 2001·Biochimica Et Biophysica Acta·I A Lorimer, S J Lavictoire
Jun 9, 2001·Endocrine-related Cancer·C T KuanD D Bigner
Apr 22, 2003·International Journal of Cancer. Journal International Du Cancer·Manuela Klingler-HoffmannTony Tiganis

❮ Previous
Next ❯

Citations

May 14, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A CustodioP Pérez-Segura
Mar 31, 2010·Proceedings of the National Academy of Sciences of the United States of America·Haoqiang YingRonald A DePinho
Mar 21, 2007·Carcinogenesis·Michael V GrandalHans S Poulsen
Apr 12, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sarah E WheelerJennifer R Grandis
Oct 1, 2009·Journal of Experimental & Clinical Cancer Research : CR·Xiao-yi DuanJian-sheng Wang
Apr 22, 2008·Neurosurgery·Johann MicallefAbhijit Guha
Feb 18, 2010·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Reema ZeineldinLaurie G Hudson
May 5, 2006·Proceedings of the National Academy of Sciences of the United States of America·Hongbin JiKwok-Kin Wong
Mar 29, 2014·Cellular and Molecular Life Sciences : CMLS·Cristina Zahonero, Pilar Sánchez-Gómez
Feb 25, 2009·Expert Opinion on Therapeutic Targets·Elizabeth A Hopper-BorgeIgor Astsaturov
Dec 18, 2007·Neoplasia : an International Journal for Oncology Research·Rushika M PereraAndrew M Scott
Apr 26, 2011·Experimental Cell Research·Marie-Thérése StockhausenHans Skovgaard Poulsen
Mar 28, 2009·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Hui K GanRodney B Luwor
May 18, 2007·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·David J RieseJeffrey Settleman
Mar 24, 2006·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Stanley S Stylli, Andrew H Kaye
Jul 19, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Mahmoud ToulanyH Peter Rodemann
Nov 21, 2012·Growth Factors·Francesca WalkerAntony W Burgess
Oct 19, 2013·Cancer Cell·Gelareh ZadehKenneth Aldape
Aug 27, 2013·Cell Reports·Vineshkumar Thidil PuliyappadambaAmyn A Habib
Apr 18, 2007·Molecular Cancer·Dimitri G TrembathGregory J Riggins
Jul 17, 2008·British Journal of Cancer·P de GraeffA G J van der Zee
Feb 23, 2019·Neurologia Medico-chirurgica·Takanori NozawaAkiyoshi Kakita
May 24, 2018·Nature Communications·Erika EngelowskiJürgen Scheller
Feb 25, 2020·Journal of Oncology·Adrianna RutkowskaPiotr Rieske

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis